Glioblastoma (GBM) is one of the most aggressive types of cancer which currently does not have a cure. Its invasive nature and heterogeneity makes its complete surgical removal impossible. Hence, a targeted treatment is critically needed to effectively eradicate this cancer. In this work, the authors report the synthesis of hollow TiO2 nanospheres (HTiO2NS) and their functionalization with folic acid (FA) and zinc (II) tet-ranitrophthalocyanine (ZnPc) to achieve cell selectivity and light absorption in the visible range. In vitro cytotoxicity of the functionalized HTiO2NS against M059K cell line (Human GBM cancer cells) was tested. In vitro generation of reactive oxygen species by HTiO2NS–FA–ZnPc nano-structures under UV irradiation was detected by fluorescence probing. To identify HTiO2NS–FA–ZnPc cell localization, the nanoparticles were labeled with fluorescein isothiocyanate dye and visualized by fluorescence microscopy. Results illustrate that HTiO2NS–FA–ZnPc nanostructures have the potential to be used for targeted photodynamic therapy for the treatment of GBM cancer.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
P.Y. Wen and S. Kesari: Malignant gliomas in adults. N. Engl. J. Med. 359, 492–507 (2008).
D.E. Dolmans, D. Fukumura, and R.K. Jain: Photodynamic therapy for cancer. Nat. Rev. Cancer 3, 380–387 (2003).
T.J. Dougherty, C.J. Gomer, B.W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and Q. Peng: Photodynamic therapy. J. Natl. Cancer Inst. 90, 889–905 (1998).
J.M. Dabrowski and L.G. Arnaut: Photodynamic therapy (PDT) of cancer: from local to systemic treatment. Photochem. Photobiol. Sci. 14, 1765–1780 (2015).
T. Tachikawa, M. Fujitsuka, and T. Majima: Mechanistic insight into the TiO2 photocatalytic reactions: design of new photocatalysts. J. Phys. Chem. C 111, 5259–5275 (2007).
C. Chawengkijwanich and Y. Hayata: Development of TiO2 powder-coated food packaging film and its ability to inactivate Escherichia coli in vitro and in actual tests. Int. J. Food Microbiol. 123, 288–292 (2008).
Z.F. Yin, L. Wu, H.G. Yang, and Y.H. Su: Recent progress in biomedical applications of titanium dioxide. Phys. Chem. Chem. Phys. 15, 4844–4858 (2013).
M. Kulkarni, A. Mazare, E. Gongadze, Š Perutkova, V. Kralj-Iglic, I. Milošev, P. Schmuki, A. Iglic, and M. Mozetic: Titanium nanostructures for biomedical applications. Nanotechnology 26, 062002 (2015).
R. Cai, Y. Kubota, T. Shuin, H. Sakai, K. Hashimoto, and A. Fujishima: Induction of cytotoxicity by photoexcited TiO2 particles. Cancer Res. 52, 2346–2348 (1992).
G. Yang, D. Yang, P. Yang, R. Lv, C. Li, C. Zhong, F. He, S. Gai, and J. Lin: A single 808 nm near-infrared light-mediated multiple imaging and pho-todynamic therapy based on titania coupled upconversion nanoparticles. Chem. Mater. 27, 7957–7968 (2015).
X. Chen and S.S. Mao: Titanium dioxide nanomaterials: synthesis, properties, modifications, and applications. Chem. Rev. 107, 2891–2959 (2007).
R. Imani, R. Dillert, D.W. Bahnemann, M. Pazoki, T. Apih, V. Kononenko, and A. Iglic: Multifunctional gadolinium-doped mesoporous TiO2 nano-beads: photoluminescence, enhanced spin relaxation, and reactive oxygen species photogeneration, beneficial for cancer diagnosis and treatment. Small 13, 1700349 (2017).
J. Schneider, M. Matsuoka, M. Takeuchi, J. Zhang, Y. Horiuchi, M. Anpo, and D.W. Bahnemann: Understanding TiO2 photocatalysis: mechanisms and materials. Chem. Rev. 114, 9919–9986 (2014).
Z. Ji, X. Jin, S. George, T. Xia, H. Meng, X. Wang, and J.I. Zink: Dispersion and stability optimization of TiO2 nanoparticles in cell culture media. Environ. Sci. Technol. 44, 7309–7314 (2010).
T. Leshuk, S. Linley, G. Baxter, and F. Gu: Mesoporous hollow sphere titanium dioxide photocatalysts through hydrothermal silica etching. ACS Appl. Mater. Interfaces 4, 6062–6070 (2012).
K. Yu, M. Ling, J. Liang, and C. Liang: Formation of TiO2 hollow spheres through nanoscale Kirkendall effect and their lithium storage and photo-catalytic properties. Chem. Phys. 517, 222–227 (2019).
D. Liu and Y.-G. Bi: Controllable fabrication of hollow TiO2 spheres as sustained release drug carrier. Adv. Powder Technol. 30, 2169–2177 (2019).
Y.G. Assaraf, C.P. Leamon, and J.A. Reddy: The folate receptor as a rational therapeutic target for personalized cancer treatment. Drug Resist. Updat. 17, 89–95 (2014).
Ł. Lamch, J. Kulbacka, M. Dubinska-Magiera, J. Saczko, and K.A. Wilk: Folate-directed zinc (II) phthalocyanine loaded polymeric micelles engineered to generate reactive oxygen species for efficacious photodynamic therapy of cancer. Photodiagnosis Photodyn. Ther. 25, 480–491 (2019).
L. Feng, C. Wang, C. Li, S. Gai, F. He, R. Li, G. An, C. Zhong, Y. Dai, Z. Yang, and P. Yang: Multifunctional theranostic nanoplatform based on Fe-mTa2O5@CuS-ZnPc/PCM for bimodal imaging and synergistically enhanced phototherapy. Inorg. Chem. 57, 4864–4876 (2018).
X. Li, B.-D. Zheng, X.-H. Peng, S.-Z. Li, J.-W. Ying, Y. Zhao, J.-D. Huang, and J. Yoon: Phthalocyanines as medicinal photosensitizers: developments in the last five years. Coord. Chem. Rev. 379, 147–160 (2019).
Z. Wang, S. Gai, C. Wang, G. Yang, C. Zhong, Y. Dai, F. He, D. Yang, and P. Yang: Self-assembled zinc phthalocyanine nanoparticles as excellent photothermal/photodynamic synergistic agent for antitumor treatment. Chem. Eng. J. 361, 117–128 (2019).
T. Lopez, E. Ortiz, M. Alvarez, J. Navarrete, J.A. Odriozola, F. Martinez-Ortega, E.A. Páez-Mozo, P. Escobar, K.A. Espinoza, and I.A. Rivero: Study of the stabilization of zinc phthalocyanine in sol-gel TiO2 for photodynamic therapy applications. Nanomedicine 6, 777–785 (2010).
Y. Shin, L. Wang, I. Bae, B.W. Arey, and G.J. Exarhos: Hydrothermal syntheses of colloidal carbon spheres from cyclodextrins. J. Phys. Chem. C 112, 14236–14240 (2008).
B. Réti, G.I. Kiss, T. Gyulavári, K. Baan, K. Magyari, and K. Hernadi: Carbon sphere templates for TiO2 hollow structures: preparation, characterization and photocatalytic activity. Catal. Today 284, 160–168 (2017).
H. Kalita, S. Konar, S. Tantubay, M.K. Mahto, and A. Pathak: Phase transformation in Mn-doped titania hollow spheres and their biocompatibility studies. Appl. Nanosci. 5, 901–910 (2015).
D. Flak, L. Yate, G. Nowaczyk, and S. Jurga: Hybrid ZnPc@TiO2 nano-structures for targeted photodynamic therapy, bioimaging and doxorubi-cin delivery. Mater. Sci. Eng. C 78, 1072–1085 (2017).
J. van Meerloo, G.J.L. Kaspers, and J. Cloos: Cell sensitivity assays: the MTT assay. Methods Mol. Biol. 731, 237–245 (2011).
T. Luttrell, S. Halpegamage, J. Tao, A. Kramer, E. Sutter, and M. Batzill: Why is anatase a better photocatalyst than rutile? - Model studies on epitaxial TiO2 films. Sci. Rep. 4, 4043 (2014).
J. Zhang, S. Rana, R.S. Srivastava, and R.D.K. Misra: On the chemical synthesis and drug delivery response of folate receptor-activated, polyethylene glycol-functionalized magnetite nanoparticles. Acta Biomater. 4, 40–48 (2008).
S. Shimizu and N. Kobayashi: Recent advances in the chemistry of phtha-locyanines as functional chromophores. In Chemical Science of π-Electron Systems, edited by T. Akasaka, A. Osuka, S. Fukuzumi, H. Kandori, and Y. Aso (Springer, Tokyo, 2015) pp. 273–291.
A.E.H. Machado, M.D. França, V. Velani, G.A. Magnino, H.M.M. Velani, F. S. Freitas, P.S. Müller Jr., C. Sattler, and M. Schmücker: Characterization and evaluation of the efficiency of TiO2/zinc phthalocyanine nanocompo-sites as photocatalysts for wastewater treatment using solar irradiation. Int. J. Photoenergy 2008, 482373 (2008).
This material is based upon work supported by a grant from the University of California Institute for Mexico and the United States (UC MEXUS) and the Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT; UCR-17091220).
The supplementary material for this article can be found at u]https://doi.org/10.1557/mrc.2019.142.
About this article
Cite this article
Uribe-Robles, M., Ortiz-Islas, E., Rodriguez-Perez, E. et al. TiO2 hollow nanospheres functionalized with folic acid and ZnPc for targeted photodynamic therapy in glioblastoma cancer. MRS Communications 9, 1242–1248 (2019). https://doi.org/10.1557/mrc.2019.142